慢病管理的药学服务模式探讨-路敏

ChineseJournalofNewDrugs2014,23(2)2442014232。[e-mail]。。[e-mail]。。[e-mail]。··11212100034。。。。Ｒ969．3A1003－3734201402－0244－03PharmaceuticalcaremodelonchronicdiseasemanagementLUMin1CUIYi-min1BAIWen-pei21DepartmentofPharmacy2DepartmentofGynecologyandObstetricsPekingUniversityFirstHospitalBeijing100034ChinaAbstractAnewmodelofpharmaceuticalpracticeonchronicdiseasemanagementunderthemacropolicywasintroduced．Wedescribedthecontentandprocessofthepharmaceuticalcarewithacaseandcomparedourswiththosereportedbyliteraturesathomeandabroad．Theclinicalpharmacistsprovideddruginformationtothecli-niciansandpersonalconsultationtothepatientsestablishedpatientprofiletofollowupandevaluatedtheoutcomesofthetreatmentinthemedicalcareteam．Theclinicalpharmacistsimprovedthemedicationuseaccuracyandcom-plianceofthepatientsandfinallyoptimizedtheoutcomesofthetreatment．Thepharmacyconsultingfeewaschargedbypharmacistforthepharmaceuticalcareservice．Thepracticebroughtbotheconomicandsocialbenefitsforthepharmacists．Itismeaningfulforclinicalpharmacisttoparticipateinchronicdiseasemanagementandpro-videpharmaceuticalcarewhichisworthfurtherexpanding．KeywordschronicdiseasemanagementpharmaceuticalcareclinicalpharmacistpharmacyconsultingfeechronicdiseasemanagementCDM、、、、、。WHO80%70%disability-adjustedlifeyears1。、、COPD、、5。。14120132“、”20mgtid20mgqd。80mgqd5mgqd。1。ChineseJournalofNewDrugs2014,23(2)2452014232。3725。10mgbid。22．120mgtid135。。10mgbid10d。5mgqd80mgqd。130/80mmHg。。。2．22．2．1《》210～20mg·d－110d。10mgbid。。、、、。。2．2．2《》2010AＲB130/80mmHg3。。。619+++62724h0．53g79μmol·L－1。2。2．36d。。d51d。。。110d4d5d。2230d28d130/80mmHg。。2．4。。3、、、、。、、。。1998chroniccaremodelCCM4、。。5。、、、、、。pharmacist-baseddisease-statemanagement6－8。《2004－2010》《2006－2015》9。、、ChineseJournalofNewDrugs2014,23(2)246201423210。1982“”11。。199717“”172312。。、。、。。、、、。、、。300。。“”。13。。。1STＲONGKMATHEＲSLEEDEＲSetal．PreventingchronicdiseaseshowmanylivescanwesaveJ．Lancet200536694961578－1582．2．J．2011469712－716．3．J．2011198701－744．4WAGNEＲEH．ChronicdiseasemanagementWhatwillittaketoimprovecareforchronicillnessJ．EffClinPract1998112－4．5HEISLEＲM．BuildingpeersupportprogramstomanagechronicdiseasesevenmodelsforsuccessJ．CalifHealthCareFound2006129－42．6ＲETAADASHTAEIALIMSetal．Opportunitiestoimproveclinicaloutcomesandchallengestoimplementingclinicalpharma-cistsintohealthcareteamsJ．PrimCare2012394615－626．7LEALSSOTOM．ChronickidneydiseaseriskreductioninahispanicpopulationthroughpPharmacist-baseddisease-stateman-agementJ．AdvChronicKidneyDis2008152162－167．8SAINIABLEMAYAKEMMEＲTONLetal．Asthmadiseasemanagement-Australianpharmacists'interventionsimprovepatients'asthmaknowledgeandthisissustainedJ．PatientEducCouns2011833295－302．9．J．2008355890－891．10．J．201240342－44．11．J．19951110327－329．12．21J．199864145－148．13WAGNEＲEHAUSTINBTVONKOＲFFM．OrganizingcareforpatientswithchronicillnessJ．MilbankQ1996744511－544．/櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃櫃2013－10－252433KOPPENHOEFEＲBZHUXJAKOBAetal．SeparationofdrugenantiomersbycapillaryelectophoresisinthepresenceofneutralcyclodextrinsJ．JChromatogrA20008751－2135－161．4QUANGCKHALEDIMG．Extandingthescopeofchiralsepara-tionbasiccompoundsbycyclodextrin-mediatedcapillaryzoneelec-tophoresisJ．JChromatogrA19956921－2253－265．5．GPⅡb/ⅢaJ．2002113197－200．6S．YBH12122004．7BECHETIPAQUESPFILLETMetal．Chiralseparationofbas-icdrugsbycapillaryzoneelectrophoresiswithcyclodextrinaddi-tivesJ．Electrophoresis1994156818－823．8．J．201021176－79．/2013－11－20